An investigation into the pathogenesis of vulvo-vaginal candidosis

S. S. El-Din, M. T. Reynolds, H. R. Ashbee, R. C. Barton, E. G.V. Evans

Research output: Contribution to journalArticleResearchpeer-review

36 Citations (Scopus)

Abstract

Objective: To monitor yeasts isolated from women during and between episodes of recurrent vulvo-vaginal candidosis (VVC) to determine whether vaginal relapse or re-infection occurred. Methods: Women presenting at the genitourinary medicine clinic with signs and symptoms of VVC were recruited to the study (n = 121). A vaginal washing, high vaginal swab (HVS) and rectal swab were taken and the women treated with a single 500 mg clotrimazole pessary. Women were asked to re-attend after 1, 4, and 12 weeks, or when the VVC recurred, when vaginal washings and HVS were repeated. Candida isolates recovered were strain typed using the Ca3 probe and their similarity assessed. Antifungal susceptibility to fluconazole and clotrimazole were determined. Results: Of the women recruited, 47 completed the study, either returning for four visits or suffering a recurrence during the study period. Of the 22 women who experienced recurrence, the same strain was responsible for the initial and recurrent episode in 17 women. For the remaining five women, four had strain replacement and one had a change of species. None of the isolates recovered from the women demonstrated resistance to either clotrimazole or fluconazole. Conclusions: Our findings support the theory of vaginal relapse and thus may support the use of more prolonged courses of antifungal therapy initially to increase the chances of eradication of the yeast.

Original languageEnglish
Pages (from-to)179-183
Number of pages5
JournalSexually Transmitted Infections
Volume77
Issue number3
DOIs
Publication statusPublished - 11 Jul 2001

Fingerprint

Candidiasis
Clotrimazole
Recurrence
Fluconazole
Yeasts
Pessaries
Candida
Signs and Symptoms
Medicine

Keywords

  • Vaginal candidosis

Cite this

El-Din, S. S. ; Reynolds, M. T. ; Ashbee, H. R. ; Barton, R. C. ; Evans, E. G.V. / An investigation into the pathogenesis of vulvo-vaginal candidosis. In: Sexually Transmitted Infections. 2001 ; Vol. 77, No. 3. pp. 179-183.
@article{6156283907824ea3aee81ef29ad9bb65,
title = "An investigation into the pathogenesis of vulvo-vaginal candidosis",
abstract = "Objective: To monitor yeasts isolated from women during and between episodes of recurrent vulvo-vaginal candidosis (VVC) to determine whether vaginal relapse or re-infection occurred. Methods: Women presenting at the genitourinary medicine clinic with signs and symptoms of VVC were recruited to the study (n = 121). A vaginal washing, high vaginal swab (HVS) and rectal swab were taken and the women treated with a single 500 mg clotrimazole pessary. Women were asked to re-attend after 1, 4, and 12 weeks, or when the VVC recurred, when vaginal washings and HVS were repeated. Candida isolates recovered were strain typed using the Ca3 probe and their similarity assessed. Antifungal susceptibility to fluconazole and clotrimazole were determined. Results: Of the women recruited, 47 completed the study, either returning for four visits or suffering a recurrence during the study period. Of the 22 women who experienced recurrence, the same strain was responsible for the initial and recurrent episode in 17 women. For the remaining five women, four had strain replacement and one had a change of species. None of the isolates recovered from the women demonstrated resistance to either clotrimazole or fluconazole. Conclusions: Our findings support the theory of vaginal relapse and thus may support the use of more prolonged courses of antifungal therapy initially to increase the chances of eradication of the yeast.",
keywords = "Vaginal candidosis",
author = "El-Din, {S. S.} and Reynolds, {M. T.} and Ashbee, {H. R.} and Barton, {R. C.} and Evans, {E. G.V.}",
year = "2001",
month = "7",
day = "11",
doi = "10.1136/sti.77.3.179",
language = "English",
volume = "77",
pages = "179--183",
journal = "Sexually Transmitted Infections",
issn = "1368-4973",
publisher = "BMJ Publishing Group",
number = "3",

}

An investigation into the pathogenesis of vulvo-vaginal candidosis. / El-Din, S. S.; Reynolds, M. T.; Ashbee, H. R.; Barton, R. C.; Evans, E. G.V.

In: Sexually Transmitted Infections, Vol. 77, No. 3, 11.07.2001, p. 179-183.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - An investigation into the pathogenesis of vulvo-vaginal candidosis

AU - El-Din, S. S.

AU - Reynolds, M. T.

AU - Ashbee, H. R.

AU - Barton, R. C.

AU - Evans, E. G.V.

PY - 2001/7/11

Y1 - 2001/7/11

N2 - Objective: To monitor yeasts isolated from women during and between episodes of recurrent vulvo-vaginal candidosis (VVC) to determine whether vaginal relapse or re-infection occurred. Methods: Women presenting at the genitourinary medicine clinic with signs and symptoms of VVC were recruited to the study (n = 121). A vaginal washing, high vaginal swab (HVS) and rectal swab were taken and the women treated with a single 500 mg clotrimazole pessary. Women were asked to re-attend after 1, 4, and 12 weeks, or when the VVC recurred, when vaginal washings and HVS were repeated. Candida isolates recovered were strain typed using the Ca3 probe and their similarity assessed. Antifungal susceptibility to fluconazole and clotrimazole were determined. Results: Of the women recruited, 47 completed the study, either returning for four visits or suffering a recurrence during the study period. Of the 22 women who experienced recurrence, the same strain was responsible for the initial and recurrent episode in 17 women. For the remaining five women, four had strain replacement and one had a change of species. None of the isolates recovered from the women demonstrated resistance to either clotrimazole or fluconazole. Conclusions: Our findings support the theory of vaginal relapse and thus may support the use of more prolonged courses of antifungal therapy initially to increase the chances of eradication of the yeast.

AB - Objective: To monitor yeasts isolated from women during and between episodes of recurrent vulvo-vaginal candidosis (VVC) to determine whether vaginal relapse or re-infection occurred. Methods: Women presenting at the genitourinary medicine clinic with signs and symptoms of VVC were recruited to the study (n = 121). A vaginal washing, high vaginal swab (HVS) and rectal swab were taken and the women treated with a single 500 mg clotrimazole pessary. Women were asked to re-attend after 1, 4, and 12 weeks, or when the VVC recurred, when vaginal washings and HVS were repeated. Candida isolates recovered were strain typed using the Ca3 probe and their similarity assessed. Antifungal susceptibility to fluconazole and clotrimazole were determined. Results: Of the women recruited, 47 completed the study, either returning for four visits or suffering a recurrence during the study period. Of the 22 women who experienced recurrence, the same strain was responsible for the initial and recurrent episode in 17 women. For the remaining five women, four had strain replacement and one had a change of species. None of the isolates recovered from the women demonstrated resistance to either clotrimazole or fluconazole. Conclusions: Our findings support the theory of vaginal relapse and thus may support the use of more prolonged courses of antifungal therapy initially to increase the chances of eradication of the yeast.

KW - Vaginal candidosis

UR - http://www.scopus.com/inward/record.url?scp=0034950264&partnerID=8YFLogxK

U2 - 10.1136/sti.77.3.179

DO - 10.1136/sti.77.3.179

M3 - Article

VL - 77

SP - 179

EP - 183

JO - Sexually Transmitted Infections

JF - Sexually Transmitted Infections

SN - 1368-4973

IS - 3

ER -